keyboard_arrow_up

New Report Explores on Biodegradable Stents Industry

Biodegraable Stentsis a new market research publication announced by Reportstack. This report gives an insight into Global Stents and Biodegradable Stents market. Estimations and predictions for biodegradable stent market are provided from 2015-2020. Business profiles of 23 biodegradable stents companies are discussed in the report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is also covered in the report.Global biodegradable stents market is projected to grow at a whopping CAGR 70.10% during the analysis period 2015-2020. Europe, following North America, is projected as the second largest market for Biodegradable Stents. 

Bioresorbable polymeric stents have become popular alternative for metallic stents as these can remain in situ for a predetermined period of time, these keep the wall of the blood vessel intact and ultimately disintegrates to non-toxic substances. A major part of the problems related to the metal stents are solved with this stent. There is evidence to support the fact that the use of bioresorbable coronary stent reduces the necessity for a substitute part after half a year. The use of bioresorbable stents is advocated in such cases where removal surgery is difficult. For e.g. in case of treatment of tracheomalacia in newborns and infants. The bioresorbable stents can help to release drugs and proteins into the blood through an intermediary wall. The biodegradable metal of magnesium alloy which was hitherto used as an orthopedic implant is now gaining popularity as a cardiovascular implant. Of these, WE43 and AE21 are a few that have gained importance as stent material.

To access full report with TOC, please visit â€‹Biodegraable Stents.

Companies Mentioned

"480 Biomedical (USA) Abbott Vascular (USA) American Medical Systems, Inc. (USA) Arterial Remodeling Technologies (ART) (France) Arterius Ltd. (UK) Biotronik SE & Co. KG (Germany) Boston Scientific Corporation (USA) Bristol-Myers Squibb Company (USA) Cedars-Sinai Medical Center (USA) Cordis Corporation (USA) Duke University (USA) Elixir Medical Corporation (USA) ELLA-CS, s.r.o. (Czech Republic) Ethicon, Inc. (USA) Eurocor GmbH (Germany) JMS Co., Ltd. (Japan) Kyoto Medical Planning Co., Ltd. (Japan) Medicines Co. (The) (USA) Medtronic, Inc. (USA) Poly-Med, Inc. (USA) Reva Medical Inc. (USA) Tepha, Inc. (USA) Xenogenics Corporation (USA) "

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

​Reportstack Market Research

###